Selected article for: "present study and virus infection"
Title: Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI)
  • Document date: 2019_10_15
    • ID: jkke8ije_1839
    Snippet: It was estimated that ~570,000 women developed cervical cancer and 260,000 died in 2018. Human Papillomavirus Virus (HPV) infection is associated with the occurrence of pre-malignant and malignant cervical lesions. The high HPV-related morbidity and mortality rates have been affected by the implementation and scale-up of national vaccination programs, early diagnosis, and appropriate clinical management. However, an increased 2-year risk of recur.....
    Document: It was estimated that ~570,000 women developed cervical cancer and 260,000 died in 2018. Human Papillomavirus Virus (HPV) infection is associated with the occurrence of pre-malignant and malignant cervical lesions. The high HPV-related morbidity and mortality rates have been affected by the implementation and scale-up of national vaccination programs, early diagnosis, and appropriate clinical management. However, an increased 2-year risk of recurrence (5%-10%) was shown in patients who underwent a surgical intervention. Aim of the present study was to evaluate the recurrence rate in patients immunized with HPV vaccine one month before or after a loop electrosurgical excision procedure (LEEP) for cervical intraepithelial neoplasia (CIN1-3).

    Search related documents:
    Co phrase search for related documents
    • appropriate clinical management and early diagnosis: 1, 2, 3, 4, 5, 6
    • appropriate clinical management and present study: 1, 2
    • appropriate clinical management early diagnosis and clinical management: 1, 2, 3
    • appropriate clinical management early diagnosis and early diagnosis: 1, 2, 3
    • cervical cancer and clinical management: 1, 2
    • cervical cancer and early diagnosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cervical cancer and electrosurgical excision: 1, 2, 3
    • cervical cancer and electrosurgical excision procedure: 1, 2, 3
    • cervical cancer and HPV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
    • cervical cancer and hpv relate: 1
    • cervical cancer and HPV vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45
    • cervical cancer and LEEP electrosurgical excision procedure: 1, 2
    • cervical cancer and loop LEEP electrosurgical excision procedure: 1, 2
    • cervical cancer and national vaccination program: 1
    • cervical cancer and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • cervical cancer and recurrence rate: 1, 2
    • cervical cancer and recurrence risk: 1
    • cervical cancer and surgical intervention: 1, 2
    • cervical cancer and vaccination program: 1, 2, 3, 4, 5, 6